
|Videos|April 1, 2022
Impact of Long-Acting HIV Prevention Drugs
A panel of experts discuss the role of PrEP in HIV prevention with a focus on current and newly approved options.
Advertisement
Episodes in this series

Now Playing
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Milestone Oral Therapy for Adults With Thalassemia Anemia
2
Reimagining Pharmacy: A Call to Action for Pharmacy Professionals
3
Lowering Blood Glucose in Prediabetes May Prevent Heart Attacks and Heart Failure
4
FDA Approves Narsoplimab-wuug for Transplant-Associated Thrombotic Microangiopathy
5








































































































































































































